Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Assembly Biosciences (ASMB) over the last 10 years, with Q3 2025 value amounting to $21.7 million.

  • Assembly Biosciences' Operating Expenses rose 2174.6% to $21.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.6 million, marking a year-over-year increase of 785.8%. This contributed to the annual value of $73.9 million for FY2024, which is 296.76% up from last year.
  • As of Q3 2025, Assembly Biosciences' Operating Expenses stood at $21.7 million, which was up 2174.6% from $20.7 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Operating Expenses peaked at $62.9 million during Q4 2021, and registered a low of $15.0 million during Q3 2023.
  • For the 4-year period, Assembly Biosciences' Operating Expenses averaged around $23.1 million, with its median value being $19.7 million (2023).
  • Data for Assembly Biosciences' Operating Expenses shows a peak YoY increase of 5459.82% (in 2021) and a maximum YoY decrease of 3494.95% (in 2021) over the last 5 years.
  • Over the past 4 years, Assembly Biosciences' Operating Expenses (Quarter) stood at $62.9 million in 2021, then plummeted by 68.65% to $19.7 million in 2023, then fell by 4.18% to $18.9 million in 2024, then grew by 14.73% to $21.7 million in 2025.
  • Its Operating Expenses stands at $21.7 million for Q3 2025, versus $20.7 million for Q2 2025 and $19.4 million for Q1 2025.